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reproduction in any medium, provided the original author and source are credited.SUMMARYTranscription factors control cell-specific gene expression programs by binding regulatory elements and recruiting cofactors and the tran-
scription apparatus to the initiation sites of active genes. One of these cofactors is cohesin, a structural maintenance of chromosomes
(SMC) complex that is necessary for proper gene expression.We report that a second SMC complex, condensin II, is also present at tran-
scriptional regulatory elements of active genes during interphase and is necessary for normal gene activity. Both cohesin and condensin II
are associated with genes in euchromatin and not heterochromatin. The two SMC complexes and the SMC loading factor NIPBL are
particularly enriched at super-enhancers, and the genes associated with these regulatory elements are especially sensitive to reduced
levels of these complexes. Thus, in addition to their well-established functions in chromosomemaintenance during mitosis, both cohe-
sin and condensin II make important contributions to the functions of the key transcriptional regulatory elements during interphase.INTRODUCTION
Transcription factors bind regulatory elements such as
enhancers and core promoters and interact with cofactors
that enable proper control of gene expression (Adelman
and Lis, 2012; Lee and Young, 2013; Lelli et al., 2012;
Roeder, 2005; Spitz and Furlong, 2012; Zhou et al.,
2012). Mediator is an essential coactivator that is re-
cruited to the regulatory regions of most active genes in
embryonic stem cells (ESCs) and many other cell types
(Kagey et al., 2010). Mediator is bound by NIPBL, which
loads cohesin at enhancers and promoters, where this
SMC complex contributes to the control of both chromo-
some structure and gene expression (Dorsett, 2011; Had-
jur et al., 2009; Parelho et al., 2008; Phillips and Corces,
2009; Schmidt et al., 2010; Seitan and Merkenschlager,
2012; Wendt et al., 2008). ESCs are highly sensitive to
reduced levels of Mediator, NIPBL, cohesin, and another
structural maintenance of chromosomes (SMC) complex
called condensin II (Fazzio and Panning, 2010; Hu
et al., 2009; Kagey et al., 2010). Condensin II is found
in the nucleus during interphase where it contributes to
interphase chromatin organization (Fazzio and Panning,
2010; Hirota et al., 2004; Ono et al., 2003, 2004) and
has been implicated in transcription (Fazzio and
Panning, 2010), but its role in gene control is not yet
understood. This study reveals that NIPBL-dependent
binding of condensin II to promoters and super-en-
hancers is an integral part of transcription activation in
ES cells.Stem Cell RRESULTS AND DISCUSSION
To gain insights into the portion of the genome occupied
by condensin II in mouse ESCs, we performed chromatin
immunoprecipitation of the condensin II subunit CAPH2
followed by massively parallel DNA sequencing (chro-
matin immunoprecipitation sequencing [ChIP-seq]) (Fig-
ure 1). To ensure that this signal represented condensin II
complexes, we confirmed the specificity of this antibody
(Figures S1A–S1C available online), verified significant
overlap with CAPD3 and another CAPH2 antibody (Figures
S1D and S1E), and demonstrated that multiple subunits of
the condensin II complex interact by ChIP western blot
(Figures 1F and 1G). The CAPH2 results showed that con-
densin II complexes occupy the enhancer and core pro-
moter regions of the well-studied ESC pluripotency gene
Pou5f1 (Figure 1A) and the global population of active
enhancers and promoters (Figure 1B), as previously noted
for Mediator, cohesin, and the cohesin loading factor
NIPBL (Kagey et al., 2010) (Table S1). The enrichment of
condensin II and cohesin at genes correlated with the
enrichment of RNA Polymerase II (Figure 1C). There were
very low levels of condensin II associated with hetero-
chromatin regions (defined by histone H3K9me3 and
H4K20me3) (Figure 1D) or insulators (defined by CTCF)
(Figure S1H). These results indicate that condensin II oc-
cupies transcriptionally active enhancer/promoter regions
in ESCs.
The yeast homolog of NIPBL, the Scc2/Scc4 complex,
promotes deposition of cohesin and condensin ontoeports j Vol. 1 j 371–378 j November 19, 2013 j ª2013 The Authors 371
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Multiple SMC Complexes at Regulatory Elementschromosomes (Ciosk et al., 2000; D’Ambrosio et al., 2008).
Mammalian NIPBL has been shown to recruit cohesin to
chromosomes, but it is not known if NIPBL also recruits
condensin (Kagey et al., 2010; Watrin et al., 2006). When
NIPBL-occupied chromatin fragments were enriched by
ChIP, antibodies against both condensin II and cohesin
subunits further enriched the enhancers of the pluripo-
tency genes Pou5f1 andNanog in a second ChIP (Figure 1E),
suggesting that NIPBL can occupy the same chromatin
fragment with both cohesin and condensin II. To investi-
gate whether NIPBL is required for deposition of condensin
II onto chromosome arms, we performed CAPH2 chro-
matin immunoprecipitation sequencing (ChIP-seq) in
ESCs with reduced NIPBL levels due to small hairpin RNA
(shRNA) knockdown (Figure 1F). Inspection of the Pou5f1
and Nanog loci revealed that reduced levels of NIPBL led
to a reduction in condensin II signal at enhancer and
promoter regions (Figure 1G). Genome-wide analysis
confirmed that enhancer and promoter regions contained
less condensin II signal when NIPBL levels were reduced
(Figure 1H). Taken together, these results indicate that
NIPBL is necessary for optimal deposition of condensin II
at active enhancer/promoter sites. It is thus possible that
NIPBL loads condensin II directly, or alternatively, that
reduced cohesin loading impacts condensin II loading.Figure 1. Condensin II and Cohesin Occupy Enhancers and Promo
(A) Binding profiles for Mediator (MED1), NIPBL, condensin II (CAPH2
shown in reads per million. Characterized enhancer regions (box labele
Yeom et al., 1996).
(B) Genome-wide distribution of NIPBL, condensin II (CAPH2), and c
defined as regions occupied by OCT4, SOX2, and NANOG (Whyte et al
promoter regions defined as regions occupied by TBP and POL II are
sentations are centered on the occupied regions, and ±1 kb is displa
(C) Condensin II and cohesin are associated with mRNA genes wit
density ±1 kb, and the transcription start site (TSS) and the average
(D) Very little condensin II or cohesin signal is observed in regions
or H4K20me3.
(E) Serial ChIP showing the presence of NIPBL with condensin II and c
elution and a second ChIP for SMC1, CAPH2, or immunoglobulin G. Th
Nanog enhancer regions. Error bars represent the SD of the average
NIPBL = 0.081, Cohesin = 0.017, and Condensin II = 0.041. At Nano
0.066) were calculated using a one-tailed t test (Supplemental Infor
(F) NIPBL mRNA levels in ESCs infected with shRNA lentiviral construct
normalized to GAPDH. The error bars represent the SD of the average of
using a one-tailed t test.
(G) Binding profiles for NIPBL in wild-type ESCs and CAPH2 in ESCs inf
ChIP-seq data are shown in reads per million. For appropriate normal
Information) and represented in rank normalized counts with the y a
(H) Genome-wide distribution of CAPH2 at enhancers and promoters in
at enhancer regions (one-tailed t test, p < 10300) defined as region
shNIPBL treatment. Right: CAPH2 levels are decreased at promoter reg
TBP and POL II upon shNIPBL treatment.
See also Figure S1 and Table S1.
Stem Cell RThe presence of condensin II at enhancer/promoter sites
occupied by the Mediator coactivator and NIPBL suggests
that it is recruited to these sites during transcription activa-
tion. To test this model, we used a well-characterized cell
system with a stably transfected doxycycline (Dox)-induc-
ible transgene (Figure 2) (Janicki et al., 2004; Zhao et al.,
2011). Dox treatment leads to expression of the rtTA
(pTet-ON) transcriptional activator, which binds to the
transgene locus and rapidly recruits POL II, resulting in
expression of the transgene (Janicki et al., 2004; Zhao
et al., 2011). Ongoing transcription of the locus can be
monitored by the binding of the YFP-tagged MS2 binding
protein (MS2-YFP) to MS2 RNA stem loops encoded by
the transgene (Janicki et al., 2004; Zhao et al., 2011). The
position of the transgene within the nucleus can be visual-
ized by the binding of a fluorescent Lac inhibitor (LacI)
protein to a tandem array of lac operator (LacO) repeats
at the locus (Figure 2A). The LacI-mCherry signal revealed
the location of the transgene in cells with and without
Dox treatment (Figure 2B). Condensin II was visualized
by immunofluorescence labeling using a specific antibody.
In the population of cells examined, there was little
colocalization of the condensin II subunit CAPH2 with
the inactive transgene (Figure 2B, top row), whereas cells
showed a clear CAPH2 signal coincident with the activeters
), and cohesin (SMC1) at the Oct4 (Pou5f1) locus. ChIP-seq data are
d E) are indicated (Okumura-Nakanishi et al., 2005; Wu et al., 2006;
ohesin (SMC1) at enhancers and promoters. Left: enhancer regions
., 2013) are enriched for condensin II, cohesin, and NIPBL. Right:
enriched for condensin II, cohesin, and NIPBL. Metagene repre-
yed.
h high POL II density. mRNA genes are ranked based on POL II
number of counts per million per base pair are displayed.
of the genome containing the heterochromatin marks H3K9me3
ohesin. NIPBL was first immunoprecipitated, followed by a peptide
e fold enrichment was determined using RT-QPCR at the Pou5f1 and
of one to three independent PCRs. p values (at Pou5f1 enhancer:
g enhancer: NIPBL = 2.9e-3, Cohesin = 2.2e-3, and Condensin II =
mation).
s targeting GFP (shGFP) and NIPBL (shNIPBL). Transcript levels were
six independent PCRs. p value (NIPBL = 2.83 107) was calculated
ected with shGFP and shNIPBL at the Pou5f1 and Nanog loci. NIPBL
ization, CAPH2 ChIP-seq data were rank normalized (Supplemental
xis floor set to 0.2.
shGFP- and shNIPBL-treated ESCs. Left: CAPH2 levels are decreased
s occupied by OCT4, SOX2, and NANOG (Whyte et al., 2013) upon
ions (one-tailed t test, p < 10300) defined as regions occupied by
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Figure 2. Recruitment of Condensin II at
Transcription Activation
(A) Schematic representation of the doxy-
cycline (Dox)-inducible transgene inte-
grated at human 1p36 in U20S-2-6-3 cells.
LacI-mCherry binds the Lac operator and
permits visualization of the locus. Dox is
required for pTet-On binding to the Tet
response element (Tet-RE). pTet-On binding
results in rapid recruitment of POL II and
gene activation, as indicated by the MS2-
YFP protein.
(B) Condensin II is recruited upon tran-
scriptional activation. U20S-2-6-3 cells
expressing LacI-mCherry were treated for
4 or 16 hr with vehicle or Dox to induce
transcription of the transgene. After cross-
linking, cells were labeled with CAPH2
antibody (Ab1). Top: minimal overlap of
CAPH2 (blue) with the transgene (LacI-
mCherry, red) in the absence of Dox. Middle
and bottom: CAPH2 (blue) is recruited to
the transgene (LacI-mCherry, red) in the
presence of 4 or 16 hr Dox. White arrows
point to nuclear localization of the trans-
gene. Representative images (n = 25) are
shown. Scale bar, 5 mm.
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bottom row) of Dox treatment. These results indicate
that condensin II is recruited to newly activated genes in
interphase cells.
Loss of ESC identity and viability has been reported
following either cohesin or condensin depletion (Fazzio
and Panning, 2010; Hu et al., 2009; Kagey et al., 2010).
Reduced levels of cohesin cause a disruption in the ESC
gene expression program (Kagey et al., 2010), but the effect
of reduced levels of condensin II on gene expression re-
mains unclear. We performed RNA-seq transcriptional
profiling of ESCs following depletion of condensin II or
cohesin (Figure 3; Table S2). We achieved similar knock-
down efficiencies for both CAPH2 and SMC1 (Figure 3A;
Figure S2A). The expression profiles for cells transduced
with two different CAPH2 shRNA constructs were similar
to one another (CAPH2 #1 versus CAPH2 #2 Spearman
correlation = 0.811) and to those of cells subjected to374 Stem Cell Reports j Vol. 1 j 371–378 j November 19, 2013 j ª2013 Thecohesin depletion (CAPH2 Avg versus SMC1 Spearman
correlation = 0.683). Genes cooccupied by condensin II
and cohesin were similarly affected by CAPH2 or SMC1
depletion, but the magnitude of change was greater when
cohesin was depleted (Figure 3B; Supplemental Informa-
tion). These observations indicate that reduced levels of
condensin II and cohesin lead to a similar disruption
of the ESC-specific gene expression program. Although
reduced levels of condensin II and cohesin have similar
effects on ESC gene expression and identity, other cell
types may not have the same requirements for both SMC
complexes (Figures 3B and S2B). Cohesin has essential
functions in DNA repair, chromosome segregation, and
probably gene expression in all cells, whereas condensin
II appears to be essential for ESCs but not MEFs (Fazzio
and Panning, 2010; Nasmyth and Haering, 2009). It is
therefore possible that the requirements for cohesin and
condensin II differ in different cells.Authors
Figure 3. Condensin II and Cohesin Depletions Disrupt the
ESC Gene Expression Program
(A) CAPH2 and SMC1 mRNA levels in ESCs infected with shRNA
lentiviral constructs. Transcript levels were normalized to GAPDH.
The error bars represent the SD of the average of three to six
independent PCRs. p values (Condensin II #1 = 2e-4, Condensin II
#2 = 3e-4, and SMC1 = 1.9e-3) were calculated using a one-tailed
t test.
(B) Gene expression changes following CAPH2 and SMC1 knock-
down at co-occupied genes. Gene expression changes were
calculated by comparing the RNA-seq data from cells transduced
with condensin II shRNA (left axis) or cohesin shRNA (right axis) to
cells transduced with control GFP shRNA. For CAPH2, two highly
similar RNA-seq data sets from two different shRNA constructs
were pooled. The 1,752 co-occupied genes were ranked based on
the average fold change for all shRNAs.
See also Figure S2 and Tables S2 and S3.
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super-enhancers, control the expression of key ESC iden-
tity genes (Whyte et al., 2013). Super-enhancers consist
of clusters of enhancers that are occupied by high levels
of Mediator and differ from typical enhancers in size, tran-
scription factor density and content, and sensitivity to
perturbation (Whyte et al., 2013). We found that NIPBL
and the two SMC complexes are enriched at super-Stem Cell Renhancers (Figures 4A and 4B). Like Mediator, there is an
increased density of cohesin, condensin II, and NIPBL
signal at the 231 ESC super-enhancers compared to the
8,563 typical enhancers (Figures 4A and 4B). Expression
of genes with super-enhancers was more sensitive to loss
of cohesin and condensin II than genes with typical en-
hancers (Figure 4C), as observed previously with pertur-
bation of other enhancer-associated factors (Whyte et al.,
2013). These results suggest that the loss of ESC gene
expression observed with cohesin and condensin II pertur-
bation might be due to direct effects on all affected genes
or alternatively, to direct effects at key super-enhancer
controlled genes such as those for the pluripotency tran-
scription factors, with consequent secondary effects on
most other active ESC genes.
We have shown that both cohesin and condensin II
occupy active enhancers and promoters in a NIPBL-depen-
dent manner, that condensin II is recruited to active pro-
moters during transcription activation in living cells, that
condensin II is required for normal levels of gene expres-
sion, and that both SMC complexes are enriched and
function at super-enhancers. Our finding that mammalian
condensin II occupies active enhancers and promoters in
a NIPBL-dependent manner is consistent with previous
studies in yeast showing that both cohesin and condensin
require the loading factor for full association with chromo-
somes (Ciosk et al., 2000; D’Ambrosio et al., 2008). Our
observation that mammalian condensin II is recruited to
active genes is consistent with work in Drosophila where
SMC complexes correlate with levels of Polymerase and
influence gene expression by facilitating DNA looping
(Lupo et al., 2001; Misulovin et al., 2008; Schaaf et al.,
2013). Finally, it is interesting that a large fraction of both
cohesin and condensin II complexes are loaded at super-
enhancers and that reduced levels of these complexes
preferentially affect expression of the key cell identity
genes associated with these large regulatory domains.
Future studies should provide additional insights into the
roles of the two different SMC complexes in coordinating
transcriptional control with chromosome organization
and maintenance.EXPERIMENTAL PROCEDURES
A detailed description of all materials and methods can be found
in the Supplemental Information.ES Cell Culture, shRNA, and Drug Treatment
V6.5 (C57BL/6-129) murine ESCs were maintained under typical
mouse ESC conditions on irradiated mouse embryonic fibroblasts
(iMEFs) as previously described (Kagey et al., 2010). For ChIP-seq
analysis, ESCs were grown two passages off iMEFs. For location
analysis following treatment, cells were grown two passages offeports j Vol. 1 j 371–378 j November 19, 2013 j ª2013 The Authors 375
Figure 4. Cohesin and Condensin II Occupy Super-Enhancers and Are Required for Proper Expression of the Key Stem Cell Identity
Genes
(A) ChIP-seq binding profiles (reads per million) for the ESC transcription factors OCT4, SOX2, and NANOG (OSN), the Mediator coactivator
(MED1), NIPBL, condensin II (CAPH2), and cohesin (SMC1) at the Gck and miR-290-295 loci in ESCs. Enhancer bars and scale bars are
depicted above the binding profiles.
(B) Metagene representations of Mediator, NIPBL, condensin II, and cohesin ChIP-seq density (reads per million per base pair) across
the 8,563 typical enhancers and the 231 super-enhancers. Metagenes are centered on the enhancer region (703 base pairs for typical
enhancers and 8.7 kb for super-enhancers), with 3 kb surrounding each enhancer region. ChIP-seq fold difference for Mediator, NIPBL,
condensin II, and cohesin at super-enhancers versus typical enhancers are displayed below the metagenes. Fold difference at enhancers
refers to the mean ChIP-seq signal (total reads) at super-enhancers divided by the mean ChIP-seq signal at typical enhancers. Fold
difference at enhancer constituents refers to the mean ChIP-seq density (reads per million per base pair) at super-enhancer constituents
divided by the mean ChIP-seq density at typical enhancer constituents.
(C) Depletion of condensin II and cohesin caused a decrease in expression of super-enhancer associated genes. Box plots of fold change
expression in condensin II and cohesin knockdown cells relative to GFP. Box plot whiskers extend to 1.53 the interquartile range. p values
(Condensin II = 7.6e-13 and Cohesin = 2.2e-20) were calculated using a two-tailed t test.
376 Stem Cell Reports j Vol. 1 j 371–378 j November 19, 2013 j ª2013 The Authors
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Multiple SMC Complexes at Regulatory ElementsiMEF feeders and treated with formaldehyde crosslinker. For
shRNA-mediated knockdowns, viral media was collected 48 hr
after cotransfection with packaging plasmids in 293T cells and
ESCs were directly infected. Knockdown ESCs were collected 3 or
5 days postinfection.ChIP-Seq and Analysis
ChIPs were performed and analyzed as previously described
(Bilodeau et al., 2009; Kagey et al., 2010; Marson et al., 2008).
For CAPH2, two antibodies (A302-275A [Ab1] and A302-276A
[Ab2], Bethyl Laboratories) were used. For ChIP-seq analysis, reads
were aligned with Bowtie (Langmead et al., 2009) and analyzed as
described in the Supplemental Information.Serial ChIP
For serial ChIP, the first immunoprecipitation was done using the
same protocol as a regular ChIP-seq experiment. Following the
first immunoprecipitation, beads were eluted twice with 100 ml
2 times; sonication buffer containing 1 mg/ml peptide specific to
the antibody for 2 3 30 min. The second ChIP was performed as
described in the Supplemental Information.Immunofluorescence Assays
U2OS-2-6-3 cells were maintained and transfected as previously
described (Janicki et al., 2004; Zhao et al., 2011). For immunofluo-
rescence studies, cells were fixed for 5 min with 2% PFA and
incubated overnight at 4C with CAPH2 antibody Ab1 (1:50,
302-275A, Bethyl Laboratories). Cells were then incubated with
a DyLight 405 nm conjugated secondary antibody (Jackson
ImmunoResearch Laboratories) for 1 hr at room temperature
andmounted in glycerol/DABCO.Maximum intensity projections
(40 3 0.2 mm z stacks) of deconvolved images are shown.
ACCESSION NUMBERS
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Procedures, two figures, and three tables and can be found
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2013.09.002.
ACKNOWLEDGMENTS
We thank Charles Lin, Pete Rahl, Zi Peng Fan, Tony Lee, Garrett
Frampton, and members of the Young laboratory for helpful
discussions and technical support, and Jeong-Ah Kwon, Vidya
Dhanapal, Jennifer Love, Sumeet Gupta, and Thomas Volkert for
assistance with ChIP-seq and RNA-seq. We thank Dr. Tatsuya
Hirano for the generous gift of the CAPD3 antibody. This work
was supported by the National Institutes of Health under Ruth L.
Kirschstein National Research Service Award (CA168263-01A1)
from the National Cancer Institute (J.M.D.), a Canadian InstitutesStem Cell Rof Health Research Fellowship (S.B.), and by NIH grants GM42694
(D.L.S.) and HG002668 (R.A.Y.).
Received: July 3, 2013
Revised: September 12, 2013
Accepted: September 13, 2013
Published: October 24, 2013REFERENCES
Adelman, K., and Lis, J.T. (2012). Promoter-proximal pausing of
RNA polymerase II: emerging roles in metazoans. Nat. Rev. Genet.
13, 720–731.
Bilodeau, S., Kagey, M.H., Frampton, G.M., Rahl, P.B., and Young,
R.A. (2009). SetDB1 contributes to repression of genes encoding
developmental regulators and maintenance of ES cell state. Genes
Dev. 23, 2484–2489.
Ciosk, R., Shirayama, M., Shevchenko, A., Tanaka, T., Toth, A.,
Shevchenko, A., and Nasmyth, K. (2000). Cohesin’s binding to
chromosomes depends on a separate complex consisting of Scc2
and Scc4 proteins. Mol. Cell 5, 243–254.
D’Ambrosio, C., Schmidt, C.K., Katou, Y., Kelly, G., Itoh, T.,
Shirahige, K., and Uhlmann, F. (2008). Identification of cis-acting
sites for condensin loading onto budding yeast chromosomes.
Genes Dev. 22, 2215–2227.
Dorsett, D. (2011). Cohesin: genomic insights into controlling
gene transcription and development. Curr. Opin. Genet. Dev. 21,
199–206.
Fazzio, T.G., and Panning, B. (2010). Condensin complexes
regulate mitotic progression and interphase chromatin structure
in embryonic stem cells. J. Cell Biol. 188, 491–503.
Hadjur, S., Williams, L.M., Ryan, N.K., Cobb, B.S., Sexton, T.,
Fraser, P., Fisher, A.G., and Merkenschlager, M. (2009). Cohesins
form chromosomal cis-interactions at the developmentally regu-
lated IFNG locus. Nature 460, 410–413.
Hirota, T., Gerlich, D., Koch, B., Ellenberg, J., and Peters, J.M.
(2004). Distinct functions of condensin I and II in mitotic chro-
mosome assembly. J. Cell Sci. 117, 6435–6445.
Hu, G., Kim, J., Xu, Q., Leng, Y., Orkin, S.H., and Elledge, S.J.
(2009). A genome-wide RNAi screen identifies a new transcrip-
tional module required for self-renewal. Genes Dev. 23, 837–848.
Janicki, S.M., Tsukamoto, T., Salghetti, S.E., Tansey, W.P., Sachida-
nandam, R., Prasanth, K.V., Ried, T., Shav-Tal, Y., Bertrand, E.,
Singer, R.H., and Spector, D.L. (2004). From silencing to gene
expression: real-time analysis in single cells. Cell 116, 683–698.
Kagey, M.H., Newman, J.J., Bilodeau, S., Zhan, Y., Orlando, D.A.,
van Berkum, N.L., Ebmeier, C.C., Goossens, J., Rahl, P.B., Levine,
S.S., et al. (2010). Mediator and cohesin connect gene expression
and chromatin architecture. Nature 467, 430–435.
Langmead, B., Trapnell, C., Pop, M., and Salzberg, S.L. (2009).
Ultrafast andmemory-efficient alignment of short DNA sequences
to the human genome. Genome Biol. 10, R25.
Lee, T.I., and Young, R.A. (2013). Transcriptional regulation and its
misregulation in disease. Cell 152, 1237–1251.eports j Vol. 1 j 371–378 j November 19, 2013 j ª2013 The Authors 377
Stem Cell Reports
Multiple SMC Complexes at Regulatory ElementsLelli, K.M., Slattery, M., and Mann, R.S. (2012). Disentangling the
many layers of eukaryotic transcriptional regulation. Annu. Rev.
Genet. 46, 43–68.
Lupo, R., Breiling, A., Bianchi, M.E., and Orlando, V. (2001).
Drosophila chromosome condensation proteins Topoisomerase II
and Barren colocalize with Polycomb and maintain Fab-7 PRE
silencing. Mol. Cell 7, 127–136.
Marson, A., Levine, S.S., Cole,M.F., Frampton,G.M., Brambrink, T.,
Johnstone, S., Guenther, M.G., Johnston, W.K., Wernig, M.,
Newman, J., et al. (2008). Connecting microRNA genes to the
core transcriptional regulatory circuitry of embryonic stem cells.
Cell 134, 521–533.
Misulovin, Z., Schwartz, Y.B., Li, X.Y., Kahn, T.G., Gause, M.,
MacArthur, S., Fay, J.C., Eisen, M.B., Pirrotta, V., Biggin, M.D.,
and Dorsett, D. (2008). Association of cohesin and Nipped-B
with transcriptionally active regions of the Drosophila mela-
nogaster genome. Chromosoma 117, 89–102.
Nasmyth, K., and Haering, C.H. (2009). Cohesin: its roles and
mechanisms. Annu. Rev. Genet. 43, 525–558.
Okumura-Nakanishi, S., Saito, M., Niwa, H., and Ishikawa, F.
(2005). Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic
stem cells. J. Biol. Chem. 280, 5307–5317.
Ono, T., Losada, A., Hirano, M., Myers, M.P., Neuwald, A.F., and
Hirano, T. (2003). Differential contributions of condensin I and
condensin II to mitotic chromosome architecture in vertebrate
cells. Cell 115, 109–121.
Ono, T., Fang, Y., Spector, D.L., and Hirano, T. (2004). Spatial and
temporal regulation of Condensins I and II inmitotic chromosome
assembly in human cells. Mol. Biol. Cell 15, 3296–3308.
Parelho, V., Hadjur, S., Spivakov, M., Leleu, M., Sauer, S., Gregson,
H.C., Jarmuz, A., Canzonetta, C., Webster, Z., Nesterova, T., et al.
(2008). Cohesins functionally associatewith CTCF onmammalian
chromosome arms. Cell 132, 422–433.
Phillips, J.E., and Corces, V.G. (2009). CTCF: master weaver of the
genome. Cell 137, 1194–1211.
Roeder, R.G. (2005). Transcriptional regulation and the role of
diverse coactivators in animal cells. FEBS Lett. 579, 909–915.378 Stem Cell Reports j Vol. 1 j 371–378 j November 19, 2013 j ª2013 TheSchaaf, C.A., Misulovin, Z., Gause, M., Koenig, A., Gohara, D.W.,
Watson, A., and Dorsett, D. (2013). Cohesin and polycomb pro-
teins functionally interact to control transcription at silenced
and active genes. PLoS Genet. 9, e1003560.
Schmidt, D., Schwalie, P.C., Ross-Innes, C.S., Hurtado, A., Brown,
G.D., Carroll, J.S., Flicek, P., and Odom, D.T. (2010). A CTCF-
independent role for cohesin in tissue-specific transcription.
Genome Res. 20, 578–588.
Seitan, V.C., and Merkenschlager, M. (2012). Cohesin and chro-
matin organisation. Curr. Opin. Genet. Dev. 22, 93–100.
Spitz, F., and Furlong, E.E. (2012). Transcription factors: from
enhancer binding to developmental control. Nat. Rev. Genet. 13,
613–626.
Watrin, E., Schleiffer, A., Tanaka, K., Eisenhaber, F., Nasmyth, K.,
and Peters, J.M. (2006). Human Scc4 is required for cohesin
binding to chromatin, sister-chromatid cohesion, and mitotic
progression. Curr. Biol. 16, 863–874.
Wendt, K.S., Yoshida, K., Itoh, T., Bando,M., Koch, B., Schirghuber,
E., Tsutsumi, S., Nagae, G., Ishihara, K., Mishiro, T., et al. (2008).
Cohesin mediates transcriptional insulation by CCCTC-binding
factor. Nature 451, 796–801.
Whyte, W.A., Orlando, D.A., Hnisz, D., Abraham, B.J., Lin, C.Y.,
Kagey, M.H., Rahl, P.B., Lee, T.I., and Young, R.A. (2013). Master
transcription factors and mediator establish super-enhancers at
key cell identity genes. Cell 153, 307–319.
Wu,Q., Chen, X., Zhang, J., Loh, Y.H., Low, T.Y., Zhang,W., Zhang,
W., Sze, S.K., Lim, B., and Ng, H.H. (2006). Sall4 interacts with
Nanog and co-occupies Nanog genomic sites in embryonic stem
cells. J. Biol. Chem. 281, 24090–24094.
Yeom, Y.I., Fuhrmann, G., Ovitt, C.E., Brehm, A., Ohbo, K., Gross,
M., Hu¨bner, K., and Scho¨ler, H.R. (1996). Germline regulatory
element of Oct-4 specific for the totipotent cycle of embryonal
cells. Development 122, 881–894.
Zhao, R., Nakamura, T., Fu, Y., Lazar, Z., and Spector, D.L. (2011).
Gene bookmarking accelerates the kinetics of post-mitotic tran-
scriptional re-activation. Nat. Cell Biol. 13, 1295–1304.
Zhou, Q., Li, T., and Price, D.H. (2012). RNA polymerase II
elongation control. Annu. Rev. Biochem. 81, 119–143.Authors
